Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22619,177,1.38 [0.86-2.23],0.180160426869065
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23651,189,2.32 [1.51-3.57],0.0001366285069782
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23402,1407,1.90 [1.61-2.24],1.8131515626811242e-14
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Candidiasis,23664,379,3.14 [2.35-4.19],7.506256654171162e-15
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22976,3469,1.84 [1.65-2.04],1.4208340662448456e-29
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22930,3485,1.87 [1.68-2.07],1.522042178797645e-31
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23450,1036,1.81 [1.49-2.19],1.3191185805203435e-09
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23585,79,2.93 [1.54-5.55],0.0010104932607314
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21448,1120,2.37 [1.98-2.83],3.553665799360647e-21
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20693,1241,2.42 [2.04-2.87],4.508331309611749e-24
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20411,251,4.09 [2.90-5.75],6.829274045459374e-16
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16645,2266,2.02 [1.77-2.30],1.049400208874583e-25
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20342,404,2.32 [1.71-3.14],5.186689011119632e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23654,1240,1.89 [1.59-2.25],5.751258913960757e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,23753,468,2.74 [2.10-3.57],1.1053718772348508e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22888,893,2.16 [1.76-2.64],1.0961471674620665e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23678,1236,2.23 [1.88-2.64],4.15730680809297e-20
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22605,191,2.38 [1.55-3.67],8.054270606039963e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23792,53,2.18 [0.96-4.98],0.0629126936404382
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23521,1079,2.26 [1.89-2.72],1.983523184744203e-18
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23578,72,1.81 [0.88-3.72],0.10795118643556
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23731,122,3.00 [1.78-5.05],3.642396667186069e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23711,102,2.91 [1.64-5.18],0.000263483934007
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22485,490,2.19 [1.67-2.88],1.8161455477644065e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22281,286,1.87 [1.29-2.70],0.0008901476881036
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22502,88,3.11 [1.69-5.73],0.0002629570241885
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23773,67,2.68 [1.33-5.40],0.0056823129238954
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23737,145,1.45 [0.86-2.45],0.163319859146737
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral warts,23645,53,0.92 [0.38-2.25],0.8599555981720037
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23643,51,2.25 [0.99-5.14],0.0542063341855262
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm,23478,347,0.73 [0.51-1.03],0.072441894851096
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23721,45,0.37 [0.16-0.85],0.0191133771349273
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23688,55,0.48 [0.21-1.09],0.0809186821116033
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23743,131,0.61 [0.35-1.09],0.0931433061148316
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23416,1638,1.35 [1.15-1.58],0.0002025152243748
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of meninges,23792,32,0.62 [0.20-1.95],0.4116831851136594
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23729,64,1.47 [0.67-3.21],0.3319238883492958
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23778,77,0.92 [0.44-1.92],0.8275459964141135
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23767,443,1.41 [1.04-1.90],0.0260878637250569
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Caecum,23762,346,1.40 [0.99-1.96],0.0556143089530346
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23663,77,0.70 [0.34-1.44],0.332617803322995
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Descending colon,23759,275,1.53 [1.05-2.22],0.0259249732065078
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,23719,422,1.24 [0.91-1.69],0.1747001704218913
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23667,729,1.36 [1.08-1.71],0.0102190011697529
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23747,562,1.48 [1.13-1.92],0.003913106351074
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18477,72,2.60 [1.29-5.24],0.0076351742817743
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18476,71,1.89 [0.90-3.97],0.0937056029174155
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23762,101,1.14 [0.60-2.16],0.6839127543908587
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma, any site",23762,98,1.07 [0.56-2.04],0.8492170194625936
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Lung cancer and mesothelioma,15835,341,2.55 [1.84-3.54],1.9679852509883967e-08
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Lymphoid leukaemia,18470,65,2.22 [1.04-4.76],0.0401200247257888
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18603,198,1.30 [0.82-2.06],0.2638088863124523
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18698,293,1.13 [0.77-1.64],0.5360274229725415
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18498,93,5.04 [2.97-8.57],2.1409213585016086e-09
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18549,144,1.13 [0.67-1.93],0.6420561900293975
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18543,138,2.22 [1.35-3.66],0.0017554672107138
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18486,81,1.53 [0.77-3.07],0.2284792182995677
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19813,1408,0.97 [0.82-1.16],0.7556630955205832
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18549,144,1.51 [0.89-2.54],0.1233674619587062
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18509,104,2.04 [1.13-3.68],0.0178350138578077
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18535,130,1.73 [0.99-3.02],0.0544280632838505
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi,23664,171,1.33 [0.81-2.16],0.2589627816328402
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi of trunk,23760,95,1.49 [0.78-2.86],0.2297911115064688
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanoma in situ,18439,74,0.80 [0.37-1.72],0.5605420612109471
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18506,101,1.96 [1.06-3.63],0.0320517454334493
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18574,169,1.49 [0.91-2.42],0.1098798724284292
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18623,218,1.73 [1.16-2.56],0.0068213995244136
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18507,102,1.80 [0.98-3.32],0.060121223922742
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,23658,137,1.46 [0.85-2.51],0.1665364124328203
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19608,1203,1.38 [1.15-1.67],0.0006654231242552
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19686,1281,1.39 [1.16-1.67],0.0003406945709403
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23519,307,2.21 [1.57-3.11],5.986877616221474e-06
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22060,119,2.83 [1.64-4.88],0.0001907180500084
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23282,70,2.81 [1.40-5.67],0.003848589320402
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23234,2786,1.96 [1.74-2.20],2.9064027496527415e-29
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22513,63,6.09 [3.29-11.25],8.225968538051007e-09
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23368,52,1.82 [0.77-4.27],0.1714261707310282
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23414,1473,1.98 [1.69-2.32],5.704075666855828e-17
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23412,1471,1.97 [1.68-2.32],8.866859086253386e-17
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22043,102,3.28 [1.83-5.87],6.233028330510119e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23550,1100,2.09 [1.74-2.51],2.379578433043929e-15
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23422,106,1.80 [0.99-3.29],0.0543973401883325
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23287,75,3.93 [2.12-7.28],1.3902016211115144e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23274,62,1.78 [0.81-3.90],0.1513295035696065
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23630,314,2.51 [1.80-3.49],5.390070986318312e-08
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23695,49,2.59 [1.13-5.94],0.0247414705706076
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23573,257,2.96 [2.07-4.23],2.447090344808142e-09
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22528,78,5.46 [3.07-9.69],6.810516651775436e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17525,376,2.20 [1.60-3.02],1.1228605707469609e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21761,163,4.80 [3.19-7.21],4.5211737662243524e-14
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21788,190,9.98 [7.18-13.88],1.3587002910738785e-42
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17206,57,3.45 [1.60-7.46],0.0016200788406441
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22419,63,1.82 [0.86-3.86],0.1204901823583808
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21654,223,2.07 [1.39-3.09],0.0003600497262298
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23289,617,1.77 [1.38-2.26],6.800518637021777e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22912,240,0.86 [0.56-1.33],0.499215578208428
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22841,169,0.95 [0.57-1.58],0.8527399378690235
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23495,1139,1.73 [1.44-2.07],2.9279810774700622e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20363,1096,2.01 [1.66-2.42],3.372974601220412e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17223,74,1.27 [0.60-2.68],0.5369183426657927
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22914,39,1.17 [0.42-3.27],0.7580717507257975
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17423,274,2.47 [1.71-3.56],1.326324608205514e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17225,76,4.21 [2.19-8.09],1.6964518109668963e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21036,3887,1.21 [1.09-1.34],0.0002550754077185
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17337,188,3.94 [2.59-6.00],1.5547225782073492e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17722,573,2.80 [2.18-3.59],5.2084089375009815e-16
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23736,278,1.45 [0.99-2.11],0.0531706179735928
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23548,90,1.17 [0.60-2.28],0.6487514159599169
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17303,154,2.86 [1.77-4.63],1.9166777718894004e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17215,66,3.69 [1.79-7.62],0.0004068086482013
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23618,743,1.80 [1.43-2.25],4.038063771447229e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17457,308,2.62 [1.85-3.69],4.347197753918922e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17530,381,3.52 [2.60-4.75],2.961609947879105e-16
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17877,728,1.51 [1.19-1.91],0.0006279215000266
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17293,144,1.19 [0.69-2.04],0.5311542014861084
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23542,84,1.19 [0.59-2.38],0.6226396917603886
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17720,571,2.62 [2.03-3.38],1.5071749511142446e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17540,391,2.90 [2.14-3.93],6.769716323302408e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21499,68,1.82 [0.86-3.86],0.1191478892374473
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22353,5204,1.41 [1.29-1.54],1.8418221370985605e-14
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22895,20,1.43 [0.35-5.87],0.6228918212559368
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22897,22,1.67 [0.44-6.25],0.4489753013619441
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23621,1773,1.13 [0.97-1.31],0.1174391336964612
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23618,1769,1.12 [0.96-1.30],0.1373200939331305
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22898,23,4.54 [1.56-13.21],0.0055819895280797
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23524,797,1.63 [1.31-2.03],1.340514777259984e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18772,1623,2.30 [1.98-2.68],3.4895540064196046e-27
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23781,266,3.37 [2.41-4.72],1.5655582747180088e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22780,108,1.72 [0.95-3.12],0.0720029969837845
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22802,75,2.07 [1.04-4.12],0.0383108575888069
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22808,81,1.17 [0.58-2.39],0.6569820627673888
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17214,65,1.14 [0.51-2.56],0.7514735507438755
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21015,169,4.18 [2.72-6.43],7.318024726208859e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2497,124,2.20 [1.32-3.68],0.0025717033801359
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2658,318,1.16 [0.84-1.62],0.3685823727796747
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20948,102,5.72 [3.37-9.70],9.883320482531192e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2452,81,2.11 [1.13-3.95],0.0195307673363972
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23005,2159,2.55 [2.25-2.90],4.625202523165922e-47
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23031,359,1.41 [1.01-1.98],0.0421877775083129
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21671,240,2.98 [2.08-4.26],2.502124489644448e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17947,798,2.50 [2.02-3.09],4.563596438750535e-17
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23667,249,1.53 [1.03-2.28],0.0344099320421847
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22564,277,1.70 [1.17-2.46],0.0050497258757946
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,20871,1492,1.33 [1.13-1.57],0.000591652504359
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22672,385,1.63 [1.19-2.24],0.0023862596068696
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22369,82,3.50 [1.90-6.44],5.711940008667268e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22537,250,3.51 [2.47-5.00],3.029391746697888e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13924,2311,1.58 [1.38-1.81],2.6261782962766804e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,AV-block,19137,623,1.35 [1.04-1.74],0.0221187644341414
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23717,538,1.22 [0.93-1.61],0.1523064687585628
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiac arrest,11862,249,2.38 [1.58-3.58],3.09784018803436e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18717,203,1.61 [1.04-2.50],0.0318245133726129
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18626,112,1.71 [0.96-3.06],0.0692410512972525
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23793,68,2.27 [1.10-4.69],0.0260347860062453
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,19876,1362,1.34 [1.13-1.60],0.0007475299314368
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21979,2624,1.44 [1.28-1.63],4.578395875681273e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20036,7756,1.42 [1.32-1.52],7.599893931907216e-21
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22560,274,1.44 [0.98-2.11],0.0621072617815953
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Endocarditis,18596,82,2.58 [1.33-5.00],0.004934207889355
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23484,1330,1.65 [1.39-1.95],1.1009534737084373e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,21239,6764,1.45 [1.34-1.57],7.58363494351756e-21
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21261,6786,1.44 [1.33-1.55],4.600815678269757e-20
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23560,110,18.32 [12.60-26.62],1.87747461245988e-52
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14656,181,3.22 [2.07-5.00],2.117227174635752e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14645,170,2.20 [1.37-3.53],0.0010515258373974
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,23645,1242,2.09 [1.76-2.48],3.606617893346007e-17
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22725,119,1.05 [0.58-1.89],0.8772015258623618
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22121,2742,1.35 [1.20-1.52],1.1023025706009432e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23365,653,1.78 [1.40-2.27],2.2602900714887125e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18933,419,1.39 [1.02-1.89],0.0399783348538334
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23061,1059,1.26 [1.04-1.53],0.0180973525720449
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20300,921,1.33 [1.08-1.63],0.0075851459734583
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23628,217,1.22 [0.80-1.86],0.3628289804226394
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23743,377,1.03 [0.74-1.43],0.8605607556297928
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Oesophageal varices,22355,69,23.35 [15.04-36.24],8.420355430071238e-45
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other aneurysm,22384,97,0.77 [0.41-1.48],0.4355075308405689
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arrhythmias,18995,481,1.29 [0.97-1.73],0.0848589260996273
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22421,134,2.88 [1.76-4.72],2.5314208288182416e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22570,283,2.10 [1.48-2.98],3.630920754319083e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18710,196,1.03 [0.65-1.64],0.88512672991907
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other disorders of veins,22385,99,1.32 [0.70-2.49],0.3829407362474606
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22336,50,1.70 [0.72-4.03],0.2243426276269114
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22198,88,2.16 [1.13-4.13],0.0199403459496836
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22394,108,0.72 [0.39-1.34],0.3032570405953007
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19767,1253,1.44 [1.21-1.72],5.964529034752909e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22469,66,18.31 [11.36-29.52],7.556449195051435e-33
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22865,578,2.01 [1.57-2.57],2.997293189991136e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23146,361,2.73 [2.02-3.69],7.526700161966104e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22778,668,1.66 [1.30-2.11],3.901210428105506e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11992,379,2.10 [1.50-2.92],1.2994431548093945e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22775,535,2.41 [1.87-3.09],5.930648084159448e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22640,354,1.30 [0.93-1.83],0.1241089974572311
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23285,500,1.05 [0.79-1.40],0.7168617017704793
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23732,718,1.37 [1.08-1.73],0.009029474189692
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18982,468,1.47 [1.09-1.96],0.0105418621864247
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23144,359,2.67 [1.97-3.62],2.3799792634438637e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22335,225,2.55 [1.73-3.76],2.4620887416032423e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23349,743,1.71 [1.36-2.14],3.262493903278952e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23333,773,1.69 [1.36-2.11],3.238244599230755e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22702,48,1.19 [0.48-2.98],0.7083824774883247
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22400,114,1.11 [0.60-2.02],0.7462863255109973
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22961,249,1.56 [1.05-2.32],0.0286615098589806
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22315,313,1.18 [0.83-1.69],0.35847142203794
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Varicose veins,22666,380,1.13 [0.81-1.57],0.48006900574994
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22304,75,1.89 [0.93-3.85],0.0784992642741798
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23554,783,1.19 [0.95-1.49],0.1363505252270785
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23596,496,5.35 [4.25-6.74],4.321635672149635e-46
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20458,966,1.85 [1.51-2.27],2.0768780523491782e-09
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,23116,3624,1.70 [1.53-1.88],4.3008723560153936e-24
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23534,584,4.43 [3.55-5.53],1.9621023066985043e-39
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20667,1175,1.96 [1.64-2.35],3.136340734490553e-13
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19577,85,1.65 [0.83-3.27],0.1493971657140514
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,23152,1527,2.03 [1.75-2.34],1.850205041101141e-21
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21352,1860,2.26 [1.98-2.58],6.2969809317896495e-34
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Vascular dementia,23281,148,2.04 [1.24-3.35],0.0049927326269123
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Alzheimer disease,23791,296,0.90 [0.61-1.32],0.5757648311396946
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15809,55,2.22 [0.94-5.27],0.0706033381035705
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Bell's palsy,22429,74,1.63 [0.79-3.36],0.185106483883236
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22689,334,1.18 [0.84-1.67],0.3442173424528487
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral cysts,23386,241,2.29 [1.56-3.38],2.5255549640349176e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23706,366,1.66 [1.21-2.29],0.0018542516620739
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23282,60,1.19 [0.52-2.72],0.6797589473852532
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23772,75,0.69 [0.32-1.45],0.3228348609125863
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23239,94,2.08 [1.11-3.88],0.0213579690761169
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,22180,286,1.57 [1.08-2.27],0.0171726898053702
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23256,1362,1.32 [1.11-1.57],0.0014280867731898
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23756,683,0.92 [0.72-1.18],0.5165350367272727
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23247,2220,1.74 [1.53-1.99],1.513279598974732e-16
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Generalized epilepsy,23402,59,2.25 [1.04-4.88],0.040057462397869
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,23623,283,1.77 [1.23-2.53],0.001972007721099
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hydrocephalus,23201,56,2.49 [1.13-5.51],0.0238458877462867
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23774,58,1.39 [0.61-3.16],0.4378011253168409
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22376,21,0.60 [0.14-2.57],0.4955489493935274
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22450,95,1.58 [0.84-2.98],0.1543300469710741
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Memory loss,23125,120,1.92 [1.10-3.35],0.0210943998882489
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,22089,195,1.32 [0.83-2.10],0.2355899176681066
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23768,175,1.68 [1.04-2.70],0.0337922876629389
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Motor neuron disease,15916,149,1.91 [1.13-3.23],0.0156989810925125
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23683,64,1.00 [0.45-2.23],0.9926589271092164
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23323,968,1.26 [1.03-1.54],0.0274579489524595
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,22475,3667,1.28 [1.15-1.42],4.314642824587735e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23465,243,1.82 [1.23-2.68],0.0027178134922319
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22745,390,1.16 [0.84-1.60],0.3747887471760029
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23701,352,2.74 [2.01-3.74],2.0896668745016677e-10
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18657,622,1.43 [1.11-1.86],0.0062570340476613
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23224,79,0.94 [0.46-1.95],0.8706272111137111
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23300,155,1.87 [1.14-3.05],0.012677715321253
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23214,141,1.01 [0.59-1.74],0.9702716434421188
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22448,93,1.67 [0.88-3.16],0.117909032686306
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other headache syndromes,21930,36,2.36 [0.86-6.46],0.0938771764764206
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,23673,528,1.87 [1.44-2.45],3.806375935414167e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,22598,704,1.17 [0.92-1.48],0.1990589102843405
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Parkinson's disease,23770,534,0.91 [0.69-1.22],0.5349130690381025
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23173,28,2.65 [0.84-8.36],0.0957843898068173
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Restless leg syndrome,23792,51,0.94 [0.38-2.31],0.8989735332710904
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Sleep apnoea,23490,635,1.14 [0.89-1.46],0.3016433750980594
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23406,57,2.26 [1.01-5.04],0.0471500573690333
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23774,174,1.69 [1.06-2.70],0.0287480188958911
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22388,33,0.79 [0.47-1.31],0.3571445937158981
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23791,299,0.91 [0.62-1.33],0.6205355974131039
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23251,144,1.97 [1.19-3.27],0.0084585126816347
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23245,87,1.42 [0.73-2.78],0.3008513298378831
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23452,299,1.10 [0.76-1.61],0.604675418059869
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23591,291,2.74 [1.95-3.86],6.9919476399485525e-09
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22919,44,1.26 [0.48-3.31],0.6378663574753767
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22935,60,1.40 [0.62-3.16],0.4118774870285995
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23700,43,2.29 [0.93-5.65],0.0712396948264464
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23564,123,1.38 [0.78-2.45],0.2701632092370172
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2456,83,2.13 [1.15-3.97],0.0166827046023699
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2994,131,1.91 [1.17-3.12],0.0094431866734046
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23250,92,2.04 [1.08-3.85],0.0277716314343116
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23541,989,1.29 [1.05-1.58],0.013485903971059
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23489,614,1.17 [0.90-1.51],0.2424158545076314
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23018,143,1.25 [0.73-2.13],0.4195558829316114
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23718,565,0.92 [0.70-1.21],0.5494908868940922
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23790,66,1.52 [0.70-3.29],0.2858679945481057
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23651,498,0.96 [0.71-1.28],0.7683613310239666
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23754,313,1.57 [1.10-2.23],0.0130869021496869
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23701,148,0.91 [0.53-1.57],0.7430844486958791
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22952,77,1.91 [0.95-3.87],0.0710104981811541
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22960,85,1.23 [0.62-2.44],0.5605881450028669
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22918,43,1.04 [0.38-2.80],0.940652548061308
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23698,680,0.90 [0.70-1.15],0.4039902340853221
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23203,185,1.15 [0.72-1.85],0.5593987989786335
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23181,28,1.08 [0.32-3.69],0.9034204359348974
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23535,94,2.21 [1.18-4.13],0.0128056669475249
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23666,225,1.38 [0.90-2.11],0.1377983684348255
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23321,168,0.75 [0.45-1.25],0.2703473870201989
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23635,82,0.54 [0.26-1.12],0.096072678022543
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23478,460,0.84 [0.62-1.14],0.2707035621708011
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23286,128,1.41 [0.81-2.45],0.223204582628967
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22416,1790,1.27 [1.09-1.47],0.0022070788918471
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23635,194,1.35 [0.86-2.14],0.1960639421182163
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23776,148,1.96 [1.19-3.24],0.0083891112921368
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23294,419,1.25 [0.92-1.71],0.1557517778850763
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23505,64,2.50 [1.20-5.24],0.0149809445376836
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23779,55,1.89 [0.83-4.30],0.1294198326071594
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22949,74,0.87 [0.41-1.88],0.7291305573649851
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23017,142,1.28 [0.75-2.17],0.3695991984961779
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22681,129,1.27 [0.72-2.24],0.4008694567180612
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23202,49,0.65 [0.26-1.63],0.3575930245907178
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22616,64,0.52 [0.23-1.18],0.1193920411008153
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23066,48,1.52 [0.61-3.76],0.3690522451458801
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23227,209,1.36 [0.88-2.12],0.1659105600668563
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22993,118,1.20 [0.67-2.16],0.5378863560995917
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22675,123,0.81 [0.45-1.47],0.486630384289247
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22647,95,1.54 [0.81-2.94],0.190851845719958
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22104,1478,1.32 [1.12-1.56],0.0011013483443159
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22932,57,0.75 [0.31-1.78],0.5089494505220185
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23545,387,1.61 [1.18-2.21],0.00288873585436
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23228,70,2.32 [1.15-4.68],0.0189388196358615
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23327,169,1.86 [1.17-2.96],0.0090172589674633
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23616,59,0.74 [0.31-1.75],0.49437825640997
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23751,122,0.96 [0.54-1.71],0.8885263714466617
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23658,112,1.85 [1.04-3.28],0.0368665798435091
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23606,49,2.50 [1.07-5.86],0.0352666545849344
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23610,53,2.04 [0.89-4.69],0.092978047786439
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23698,960,1.43 [1.16-1.75],0.0006824795062387
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23446,708,1.54 [1.21-1.95],0.0003662197205613
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22868,130,0.91 [0.51-1.61],0.7336239500744108
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22824,86,1.92 [0.99-3.71],0.0535818928727649
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute pharyngitis,23579,62,2.46 [1.17-5.18],0.0173986616750287
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23706,189,1.65 [1.05-2.58],0.028876507106904
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23578,61,1.54 [0.69-3.42],0.2887947642399846
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,All influenza,21509,108,2.01 [1.10-3.66],0.0227070430233368
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21506,105,1.87 [1.02-3.45],0.0444402888497823
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15596,102,1.54 [0.80-2.95],0.1960145236248725
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Allergic rhinitis,23684,267,0.88 [0.59-1.32],0.5319701086636403
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16569,1422,1.48 [1.25-1.76],7.892996523051184e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16892,1398,1.48 [1.24-1.76],1.2082383272121713e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23411,151,1.74 [1.06-2.85],0.0285314666288183
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21497,96,1.56 [0.83-2.96],0.169000023349124
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Bronchiectasis,20698,291,1.73 [1.20-2.50],0.0036240275640757
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20451,44,4.33 [1.90-9.89],0.0005013771126611
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22948,2541,1.57 [1.38-1.77],1.345054976085176e-12
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22348,79,0.54 [0.27-1.09],0.0863537150921871
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic sinusitis,22430,161,1.25 [0.76-2.06],0.381229186468476
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23571,1295,2.08 [1.76-2.46],5.327087340071661e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Deviated nasal septum,22409,140,0.70 [0.40-1.20],0.1918530548612728
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21790,5275,1.57 [1.44-1.71],9.100669434528325e-24
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22658,389,1.25 [0.91-1.72],0.1748944572353903
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,22576,300,2.88 [2.11-3.94],2.622845456197748e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Emphysema,20755,348,2.60 [1.90-3.55],2.105138359267933e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22867,335,2.25 [1.62-3.12],1.1814578261056684e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23548,2147,1.89 [1.66-2.16],5.119767859217994e-21
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,22896,364,2.27 [1.66-3.11],2.7875705483731134e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Later onset COPD,22733,995,1.86 [1.53-2.26],5.31588533788865e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23775,421,1.84 [1.37-2.48],5.605304293960507e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Nasal polyp,22413,144,0.99 [0.58-1.68],0.9604027250197918
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23521,1003,1.69 [1.39-2.06],1.204821024642095e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,23516,2204,1.90 [1.67-2.16],4.346384628642143e-22
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23140,871,1.03 [0.83-1.29],0.7591828420592841
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other pleural conditions,21378,66,6.51 [3.54-11.99],1.797605813120095e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23701,446,2.19 [1.65-2.91],4.9656008500925856e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23670,1397,1.73 [1.47-2.04],4.6216583894815095e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,22434,1122,2.24 [1.88-2.68],5.024111374133822e-19
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural plaque,21579,267,2.39 [1.65-3.47],4.269143166612321e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23284,1883,1.86 [1.61-2.14],9.65633345902496e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23678,324,1.80 [1.28-2.53],0.0007488346242365
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pneumothorax,21455,143,1.85 [1.10-3.11],0.0203220869651857
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pollen allergy,23777,233,0.92 [0.60-1.42],0.7056838134793213
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pulmonary oedema,23322,67,3.55 [1.82-6.92],0.0001982678208357
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15548,54,1.83 [0.77-4.30],0.1688001300250709
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23503,985,1.74 [1.43-2.12],2.7472368071907616e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22538,269,0.89 [0.60-1.34],0.5871013630974942
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Viral pneumonia,21683,282,1.68 [1.16-2.45],0.006584894722992
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23430,239,1.85 [1.24-2.76],0.0026222749486967
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10368,115,2.21 [1.24-3.97],0.0075235274865055
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16614,90,2.40 [1.29-4.49],0.0059121217365402
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute appendicitis,23656,144,0.98 [0.57-1.67],0.932975761880238
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute gastritis,17961,90,2.97 [1.57-5.63],0.0008086400550423
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,22438,202,3.04 [2.02-4.57],1.012178948930793e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute peritonitis,23427,98,5.05 [2.98-8.56],1.901296086992298e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22905,117,21.18 [14.87-30.18],4.5209756479973245e-64
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Barrett oesophagus,18395,524,2.28 [1.74-2.99],2.302145459614855e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22357,121,2.15 [1.24-3.72],0.0062539087624253
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23385,121,2.08 [1.20-3.60],0.0092081545990088
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,22454,218,1.50 [0.98-2.29],0.0634741614517226
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,23023,787,2.05 [1.65-2.55],8.591205677029057e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,18136,265,2.16 [1.48-3.17],7.442060356871941e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22293,57,4.63 [2.32-9.24],1.3364600686851786e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23583,133,17.99 [12.76-25.36],3.648719755192003e-61
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,22161,92,8.35 [5.13-13.57],1.1453790585802224e-17
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Collagenous colitis,22349,49,1.46 [0.60-3.56],0.4028796329125264
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23626,220,1.15 [0.75-1.76],0.5269007831368516
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,23629,1590,1.47 [1.26-1.72],1.6066155552092186e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,22392,92,1.99 [1.05-3.76],0.0346774581260979
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23447,66,2.01 [0.95-4.23],0.0677854244972067
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22378,78,1.73 [0.86-3.48],0.1214754591913373
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,23150,226,1.92 [1.30-2.86],0.0011581955800987
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20154,1950,1.53 [1.32-1.76],7.04839245974469e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of appendix,23688,176,0.97 [0.60-1.58],0.9186330777063892
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,23654,866,4.31 [3.57-5.19],5.650392385565012e-53
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21811,3940,1.66 [1.50-1.84],5.49000373772788e-23
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23431,507,1.86 [1.42-2.43],5.795701386106977e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23742,413,2.23 [1.66-3.00],1.1216223186481689e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23031,107,1.89 [1.05-3.39],0.033479026100861
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22891,64,1.13 [0.52-2.49],0.75573884739442
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23477,1408,1.88 [1.60-2.21],3.021927018011728e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of tongue,22911,109,2.33 [1.31-4.13],0.0038934221493015
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23422,1186,2.23 [1.87-2.65],1.4615720668265455e-19
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19573,3049,1.34 [1.19-1.51],7.258395355614041e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,18139,268,2.55 [1.77-3.69],6.147897605145685e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23679,210,2.39 [1.60-3.57],2.013765201589376e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23718,47,3.08 [1.34-7.08],0.0079313796139252
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22944,156,14.91 [10.67-20.83],2.2567966977120777e-56
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16704,180,0.95 [0.58-1.54],0.8269822079710731
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Functional dyspepsia,18292,421,1.37 [1.00-1.88],0.0491958214573547
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,18235,364,2.37 [1.72-3.26],1.1408514065835605e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20022,2151,1.60 [1.39-1.83],2.9966118705829813e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18466,595,2.24 [1.74-2.88],2.9529975110747767e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18185,7980,1.35 [1.26-1.45],4.0171424041084813e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,23241,1172,1.72 [1.43-2.06],4.242400865590936e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22969,45,1.97 [0.81-4.80],0.1365819842384869
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17489,1233,1.11 [0.92-1.34],0.2732346212874071
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22875,87,8.98 [5.34-15.08],1.1223232549196246e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,21743,3539,1.25 [1.12-1.39],7.025529003831797e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impacted teeth,23721,44,2.99 [1.26-7.12],0.0131011372938531
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impaction of intestines,16571,47,1.20 [0.47-3.06],0.7017063244290626
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Inguinal hernia,19834,1630,0.91 [0.77-1.07],0.2396472265997803
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18403,199,0.73 [0.46-1.18],0.2003893180971587
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16613,89,2.20 [1.15-4.19],0.0166420600375905
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22174,105,7.35 [4.59-11.78],1.1353384278833792e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16799,275,1.49 [1.02-2.19],0.0410359120942281
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23752,377,3.91 [2.93-5.20],9.910774013677296e-21
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22980,680,1.96 [1.55-2.47],1.7228119118176573e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23190,890,1.78 [1.45-2.19],3.932597746460416e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18083,212,2.58 [1.70-3.91],7.456706630394933e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,18500,629,2.45 [1.92-3.12],3.783472114067287e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23740,114,1.05 [0.58-1.92],0.8611735589008875
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18281,77,1.26 [0.61-2.64],0.533193156505883
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17957,1433,1.49 [1.26-1.77],3.0702047828181293e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22493,257,1.91 [1.30-2.81],0.0009152737969012
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22354,118,2.10 [1.20-3.68],0.0096724556573542
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,18400,1876,1.54 [1.33-1.78],6.905100767380251e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,21980,5456,1.38 [1.26-1.50],3.5043853332741693e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22876,181,1.07 [0.67-1.73],0.7729953385838646
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,23478,690,3.94 [3.18-4.87],2.0238040056443384e-36
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18605,734,2.22 [1.76-2.78],9.020019199445047e-12
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22377,141,3.27 [2.04-5.24],7.826169820128339e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23671,342,1.82 [1.31-2.54],0.0004174322503676
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18675,804,3.19 [2.58-3.94],3.461798635583131e-27
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23251,1182,1.70 [1.42-2.04],7.107498228059931e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23101,177,1.66 [1.05-2.62],0.0290696625673074
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18151,1627,1.58 [1.35-1.85],8.9521024878235e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19747,1876,2.02 [1.75-2.33],9.130425790552516e-22
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22884,96,7.71 [4.63-12.84],4.518301447218083e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23079,779,1.93 [1.55-2.41],3.3981836286613796e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16875,351,1.68 [1.20-2.34],0.0024324761697247
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23710,56,3.09 [1.44-6.61],0.0036356289969781
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17001,477,1.65 [1.24-2.20],0.0006528995214975
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22235,166,2.18 [1.36-3.48],0.0011187707175883
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23779,44,1.58 [0.62-4.04],0.3419068882970689
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22933,106,2.69 [1.52-4.74],0.0006583503700484
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Toxic colitis,22346,46,1.63 [0.65-4.14],0.2997983435869796
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18170,299,2.16 [1.51-3.08],2.366500226811297e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcerative colitis,22449,149,1.33 [0.79-2.26],0.2816119108149809
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22425,125,1.03 [0.58-1.84],0.9141928680470724
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Umbilical hernia,18572,368,1.35 [0.97-1.88],0.0785865332393589
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16682,158,2.27 [1.40-3.69],0.0009546769387585
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,18463,259,1.79 [1.21-2.62],0.0031647986799502
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Volvulus,16598,74,0.98 [0.45-2.12],0.9580145915305148
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23716,329,1.12 [0.78-1.61],0.5235623281538888
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23473,66,4.81 [2.49-9.31],3.03521117338566e-06
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21798,97,1.48 [0.77-2.82],0.2365260206286538
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23057,764,1.50 [1.20-1.88],0.0003909358575291
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22494,201,1.76 [1.14-2.70],0.010197980497856
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22168,467,1.79 [1.36-2.37],4.387231649662157e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23499,266,1.82 [1.25-2.66],0.0017779255964938
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23703,470,1.78 [1.34-2.37],6.170523186124722e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23277,44,2.49 [1.00-6.19],0.0489588863128755
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22307,3178,1.30 [1.17-1.46],3.5967011671609006e-06
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23343,409,1.07 [0.78-1.46],0.692746216337033
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23231,297,1.03 [0.71-1.49],0.8945175465181886
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23332,1039,1.43 [1.18-1.74],0.0002733486179375
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23782,30,1.48 [0.47-4.65],0.5032196486188963
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21724,23,5.41 [1.84-15.90],0.0021432945818566
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22991,57,1.59 [0.70-3.64],0.2712448269854864
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23495,262,1.81 [1.24-2.65],0.0022306957645964
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22183,482,1.11 [0.83-1.49],0.4879705364114758
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21781,80,1.00 [0.49-2.07],0.9936212469368793
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23726,83,1.14 [0.57-2.27],0.7177091071350219
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22512,219,1.67 [1.10-2.53],0.01568579200192
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23624,217,1.70 [1.12-2.58],0.0134412307556603
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23304,71,1.17 [0.55-2.49],0.6745563768445635
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21767,66,0.50 [0.23-1.10],0.0864893014345525
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23336,1635,1.32 [1.13-1.54],0.000535965686987
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22224,523,1.17 [0.88-1.56],0.2740802231926939
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21784,83,1.08 [0.53-2.19],0.834916550255867
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23703,296,1.75 [1.22-2.50],0.0022608838717675
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23288,55,2.25 [1.02-4.96],0.0441259885033573
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23667,260,1.85 [1.27-2.70],0.0014920217600464
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23736,349,1.06 [0.75-1.51],0.7298711917152452
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21791,90,1.48 [0.75-2.89],0.2553465559664409
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21972,271,0.71 [0.48-1.05],0.0882647461215961
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23729,342,1.11 [0.78-1.58],0.5491725633080127
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21974,273,2.25 [1.58-3.21],7.758780225840266e-06
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23766,123,1.07 [0.60-1.89],0.8278006277754675
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20539,91,2.83 [1.54-5.22],0.0008633862656706
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21706,4770,1.19 [1.08-1.31],0.0002651469137075
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20303,3367,1.11 [0.99-1.24],0.0731437058875205
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20520,72,1.19 [0.56-2.54],0.648429762355489
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20892,152,2.01 [1.23-3.29],0.0054642598868206
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20883,143,1.51 [0.89-2.55],0.1240493286050415
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23590,68,0.85 [0.39-1.83],0.6708950331099217
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20818,78,2.12 [1.07-4.21],0.0319108402130932
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17804,868,1.10 [0.88-1.38],0.3962796223323703
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23675,149,1.06 [0.62-1.79],0.8377185143455118
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21009,269,1.28 [0.86-1.89],0.2201377690062898
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20247,6253,1.22 [1.12-1.32],2.0334739273467224e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22735,90,1.83 [0.96-3.48],0.0664067397079135
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20615,167,1.26 [0.77-2.06],0.3603046709597439
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20882,434,1.19 [0.87-1.61],0.2801544652762311
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22970,2230,1.35 [1.18-1.55],1.1143026836484732e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20812,364,1.63 [1.17-2.27],0.0038027729501089
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20502,54,1.99 [0.87-4.56],0.1048592676975023
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20541,93,0.86 [0.43-1.70],0.656412615457481
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23472,30,0.72 [0.22-2.31],0.57707175952547
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18400,1464,1.08 [0.91-1.28],0.3541683869734844
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17921,985,1.43 [1.17-1.75],0.0005722938372446
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23651,971,1.40 [1.14-1.71],0.0011835832278764
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16985,49,1.22 [0.48-3.12],0.6745627911964417
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17014,78,0.74 [0.35-1.58],0.4409379517729928
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20719,271,1.16 [0.79-1.72],0.4454345636329369
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17568,632,1.03 [0.79-1.34],0.8298522667558494
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20781,41,2.23 [0.87-5.73],0.096455249586892
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21273,533,1.39 [1.05-1.82],0.0198838880702416
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21006,266,1.17 [0.79-1.73],0.4412825378045083
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17527,591,1.02 [0.78-1.34],0.8878923672232912
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20514,66,1.19 [0.54-2.61],0.6705370654319597
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20501,53,1.11 [0.46-2.68],0.8094072901348631
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22737,92,4.06 [2.30-7.18],1.3748026638938035e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23504,859,1.81 [1.47-2.23],2.193128118668699e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23045,400,1.94 [1.44-2.62],1.544759720266891e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23710,289,1.53 [1.06-2.21],0.0221089043288752
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18815,1879,1.24 [1.06-1.44],0.0053612448143141
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16987,51,0.78 [0.31-2.00],0.6062875152149141
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20532,84,1.02 [0.50-2.06],0.9583259961675068
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16991,55,0.93 [0.38-2.29],0.8814343260528819
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16981,45,1.38 [0.53-3.62],0.5086518255176637
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22831,186,1.26 [0.79-1.99],0.3346357554592526
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22806,161,1.49 [0.91-2.46],0.1154696778931961
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23756,85,0.99 [0.49-1.98],0.9744578895471516
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22265,1525,1.41 [1.20-1.66],2.736800490728748e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20515,67,1.32 [0.61-2.89],0.4814688486724058
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16976,40,1.72 [0.63-4.73],0.2919181488262573
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21351,611,1.59 [1.23-2.05],0.0003745158863559
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18649,1713,1.18 [1.01-1.38],0.0418746951818822
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23497,55,0.95 [0.40-2.25],0.907022395997101
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23774,60,5.59 [2.86-10.93],5.06758898472001e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20528,80,0.99 [0.48-2.02],0.9742237055066456
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21438,990,1.34 [1.10-1.64],0.0044385537036979
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20543,95,1.09 [0.57-2.12],0.7888813463782138
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18133,1197,1.25 [1.04-1.51],0.0190172916059028
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22731,86,1.07 [0.54-2.13],0.8525173847526764
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20493,45,1.85 [0.72-4.72],0.198528980925236
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20851,111,1.84 [1.02-3.32],0.0426001286201988
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20957,509,1.32 [1.00-1.75],0.0517838812570432
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23636,194,1.35 [0.85-2.15],0.1965945111438899
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21221,481,1.53 [1.15-2.04],0.0036063010210159
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23719,283,1.56 [1.08-2.26],0.0177400414194697
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23778,37,2.29 [0.86-6.13],0.0982087415568773
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20599,151,1.51 [0.90-2.51],0.1168397191155521
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19504,576,1.85 [1.42-2.40],4.259729321931689e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20933,485,1.26 [0.95-1.69],0.1143625086252023
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20777,329,1.60 [1.13-2.27],0.0079638241661029
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16966,30,3.39 [1.18-9.80],0.023912848826641
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19198,2262,1.35 [1.18-1.55],1.145582003465632e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17388,452,1.05 [0.77-1.42],0.7752706703550696
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23605,163,1.09 [0.65-1.82],0.7355236466447722
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23717,46,1.19 [0.46-3.05],0.7201534255605866
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21807,45,0.59 [0.22-1.60],0.3029734221850731
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16998,62,5.51 [2.79-10.88],9.010250188395664e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20828,88,0.79 [0.40-1.58],0.5054314908902277
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17233,297,1.64 [1.14-2.36],0.0080836958960919
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20726,278,1.15 [0.78-1.68],0.4908220442424703
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20956,216,1.56 [1.01-2.39],0.0426171752881772
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20834,94,1.25 [0.64-2.45],0.5077610676377571
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18893,31,1.26 [0.40-3.98],0.6978121257662179
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23779,38,2.36 [0.90-6.17],0.0798036665560656
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20975,527,1.30 [0.99-1.71],0.0636102430265928
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23462,20,2.14 [0.55-8.33],0.2746780327216639
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22722,2274,1.24 [1.08-1.41],0.0019881307750394
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20553,105,0.91 [0.49-1.72],0.7823428593761872
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21243,503,1.43 [1.08-1.90],0.0134048442888524
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22730,197,1.49 [0.95-2.33],0.0840362889538398
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20868,128,0.93 [0.52-1.65],0.8093061679415086
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22056,1316,1.41 [1.18-1.68],0.0001233940030719
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21564,824,1.36 [1.09-1.70],0.0057485110614382
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20491,43,1.05 [0.39-2.82],0.927331425730353
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23482,40,5.25 [2.34-11.81],5.884737866578641e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20567,119,0.94 [0.52-1.70],0.8420599488408502
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20469,21,0.94 [0.23-3.79],0.927863055087756
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16995,59,1.38 [0.60-3.17],0.4533287649342014
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22784,1867,2.03 [1.77-2.34],3.499761215674037e-23
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23318,407,1.18 [0.86-1.61],0.3092906333429033
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23052,141,1.10 [0.64-1.89],0.7185699599961308
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22468,1551,1.50 [1.27-1.75],7.812462982889689e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23541,85,1.05 [0.53-2.09],0.8932895386361208
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23508,355,1.20 [0.86-1.69],0.2870533312183813
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,20920,214,1.70 [1.11-2.62],0.0150097786977156
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Dialysis,21021,104,1.87 [1.03-3.41],0.0397000919349489
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22505,3316,0.98 [0.88-1.10],0.7161713079994607
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21415,5586,1.28 [1.17-1.39],2.3063147342783083e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23559,103,3.40 [1.95-5.92],1.6127204137919666e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydrocele,19394,205,0.68 [0.43-1.06],0.0909526617205356
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21023,369,1.30 [0.93-1.81],0.1251899073891472
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21799,2610,1.01 [0.89-1.14],0.9249041641654115
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19423,234,0.69 [0.45-1.06],0.0913244462946328
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20785,79,1.12 [0.55-2.31],0.749554671534959
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19295,106,1.42 [0.78-2.60],0.2544067533809307
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23780,62,2.00 [0.93-4.31],0.0751625677099653
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23786,58,1.79 [0.80-4.00],0.1532369248849972
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22964,2258,1.30 [1.14-1.49],0.0001131839306043
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21659,953,1.09 [0.88-1.35],0.4107215514562338
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23716,563,1.27 [0.97-1.66],0.0796205411794307
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19498,309,0.97 [0.67-1.40],0.8723677119918132
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19466,277,1.15 [0.79-1.69],0.4654767285176789
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19415,226,0.73 [0.47-1.12],0.1508285286927293
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23775,49,0.78 [0.31-1.96],0.6014111575099383
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22243,1537,1.54 [1.31-1.80],1.6651107114890457e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21069,415,1.28 [0.93-1.75],0.1261881194491147
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23344,191,1.27 [0.80-2.01],0.3094296703321756
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23512,56,2.10 [0.93-4.72],0.0732970282125077
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19453,264,1.32 [0.90-1.95],0.1570736114092594
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23490,2836,1.65 [1.47-1.86],3.136992440469392e-17
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20729,75,2.04 [1.01-4.13],0.0479005983088954
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21075,158,3.06 [1.95-4.83],1.3189116699459334e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22988,77,1.65 [0.82-3.34],0.1627344772233232
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21001,295,1.40 [0.96-2.02],0.0775923234334173
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23436,525,1.22 [0.92-1.61],0.1648596329541686
